Atomistry » Chlorine » PDB 5mlx-5mtr » 5mo4
Atomistry »
  Chlorine »
    PDB 5mlx-5mtr »
      5mo4 »

Chlorine in PDB 5mo4: ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib

Enzymatic activity of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib

All present enzymatic activity of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib:
2.7.10.2;

Protein crystallography data

The structure of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib, PDB code: 5mo4 was solved by S.W.Cowan-Jacob, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 59.14 / 2.17
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 118.280, 124.130, 74.660, 90.00, 90.00, 90.00
R / Rfree (%) 18.2 / 21.7

Other elements in 5mo4:

The structure of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib also contains other interesting chemical elements:

Fluorine (F) 5 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib (pdb code 5mo4). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib, PDB code: 5mo4:

Chlorine binding site 1 out of 1 in 5mo4

Go back to Chlorine Binding Sites List in 5mo4
Chlorine binding site 1 out of 1 in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl602

b:26.2
occ:1.00
CL A:AY7602 0.0 26.2 1.0
C28 A:AY7602 1.8 29.4 1.0
F30 A:AY7602 2.5 31.4 1.0
F29 A:AY7602 2.7 28.6 1.0
O22 A:AY7602 2.7 28.8 1.0
C19 A:AY7602 3.2 28.7 1.0
O A:LEU448 3.3 24.8 1.0
C20 A:AY7602 3.6 25.5 1.0
CG2 A:ILE451 3.8 24.6 1.0
N A:ALA452 3.9 24.0 1.0
CG1 A:VAL487 4.0 25.4 1.0
CB A:ILE451 4.0 24.8 1.0
CD1 A:LEU448 4.0 31.8 1.0
CG A:LEU448 4.1 31.3 1.0
C A:LEU448 4.1 26.3 1.0
CB A:ALA452 4.1 23.8 1.0
C18 A:AY7602 4.1 29.5 1.0
CA A:LEU448 4.2 23.9 1.0
CA A:ALA452 4.3 23.7 1.0
CB A:ALA363 4.5 23.0 1.0
C A:ILE451 4.5 28.0 1.0
CB A:LEU448 4.6 25.0 1.0
C21 A:AY7602 4.6 26.9 1.0
CA A:ILE451 4.8 22.8 1.0
CE A:MET491 4.9 26.9 1.0

Reference:

A.A.Wylie, J.Schoepfer, W.Jahnke, S.W.Cowan-Jacob, A.Loo, P.Furet, A.L.Marzinzik, X.Pelle, J.Donovan, W.Zhu, S.Buonamici, A.Q.Hassan, F.Lombardo, V.Iyer, M.Palmer, G.Berellini, S.Dodd, S.Thohan, H.Bitter, S.Branford, D.M.Ross, T.P.Hughes, L.Petruzzelli, K.G.Vanasse, M.Warmuth, F.Hofmann, N.J.Keen, W.R.Sellers. The Allosteric Inhibitor ABL001 Enables Dual Targeting of Bcr-ABL1. Nature V. 543 733 2017.
ISSN: ESSN 1476-4687
PubMed: 28329763
DOI: 10.1038/NATURE21702
Page generated: Sat Jul 12 05:34:07 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy